Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
5
ARVN Quote, Financials, Valuation and Earnings
Last price:
$8.39
Seasonality move
:
-15.98%
Day range:
$8.38 - $8.86
52-week range:
$7.91 - $45.03
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.37x
P/B ratio:
1.07x
Volume:
2.1M
Avg. volume:
2.3M
1-year change:
-80.6%
Market cap:
$598.3M
Revenue:
$263.4M
EPS (TTM):
-$2.77
ARVN Analysts' Consensus Rating
The 18 analysts providing 12-month price projections for Arvinas shares anticipate an average target of $45.26, ranging from a low estimate of $10.00 to a high estimate of $110.00. This average target implies a growth of 420.27% compared to the current stock price of $8.70.
Consensus Price Target
$45.26
Highest Price Target
$110.00
Lowest Price Target
$10.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 13 | 15 | 13 |
| Hold | 2 | 2 | 5 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
ARVN Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
